What is Adamax (DW 1032)?
Adamax is listed under the code DW 1032. Public descriptions disagree about its structure: a vendor-deposited PubChem substance record describes an acetylated nine-residue peptide containing Semax, while other supplier descriptions include an adamantane group. The existing guide assigns Adamax no confirmed structure and identifies no peer-reviewed study under that name or code. Semax findings are context, not Adamax evidence.
What the research covers
A PubMed search for Adamax returns papers on AdaMax, an unrelated machine-learning method, and none on this peptide, and searches for DW 1032 and for adamantane-modified Semax return nothing relevant. No cell, animal or human study of Adamax is on record. The summaries below cover Semax and two published Semax variants, each with its model and the compound tested. None of them tested Adamax. Semax is the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, which joins positions 4 to 7 of adrenocorticotropic hormone to a Pro-Gly-Pro tail that adds resistance to peptidases.
What is Adamax?
They give no sequence, formula, molecular weight or CAS number, and they do not say what DW 1032 stands for.
No peer-reviewed study of Adamax appears in PubMed under that name or code. This guide sets out what is and is not on record, then summarizes the literature on Semax, the peptide that supplier descriptions of Adamax build on, labeled as Semax data throughout.
Adamax reference data
| Property | Value |
|---|---|
| Name | Adamax (DW 1032) |
| Category | Neurocognitive research |
| Sequence and formula | No PubChem compound record, so no verified formula is given here |
| Molecular weight | No verified figure is given here (no PubChem compound record) |
| CAS number | No CAS number found in PubChem |
| Aerosol spray | Pre-formulated liquid, 1 mg/mL in a 10 mL bottle, 10 mg total |
PubChem has no compound record for Adamax or DW 1032. One vendor-deposited PubChem substance record (SID 513899171) lists Adamax as a synonym of Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly-OH, an acetylated nine-residue peptide containing the full Semax sequence, without a standardized structure. Supplier listings elsewhere describe an acetylated Semax with an adamantane group at the C-terminus instead. These descriptions disagree and none is peer-reviewed, so this guide assigns Adamax no structure. Identity for a given lot rests on its certificate.
What the research covers
A PubMed search for Adamax returns papers on AdaMax, an unrelated machine-learning method, and none on this peptide, and searches for DW 1032 and for adamantane-modified Semax return nothing relevant. No cell, animal or human study of Adamax is on record. The summaries below cover Semax and two published Semax variants, each with its model and the compound tested. None of them tested Adamax.
Semax, the parent sequence
Semax is the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, which joins positions 4 to 7 of adrenocorticotropic hormone to a Pro-Gly-Pro tail that adds resistance to peptidases. Our Semax research guide covers that literature in depth.
Neurotrophin signaling and ischemia (Semax, rat)
Tritium-labeled Semax bound specific, calcium-dependent sites in rat basal forebrain membranes with a dissociation constant of about 2.4 nM, and Semax raised basal forebrain BDNF protein at 3 hours (Dolotov et al., 2006a). In rat hippocampus, one application raised BDNF protein up to 1.4-fold and trkB phosphorylation 1.6-fold (Dolotov et al., 2006b). After permanent middle cerebral artery occlusion in rats, immune-system genes made up more than half of the genes Semax changed at 24 hours (Medvedeva et al., 2014). Compound tested in all three: Semax, not Adamax.
Breakdown and modified Semax peptides
Incubated with nerve cells, Semax was broken down mainly to His-Phe-Pro-Gly-Pro and Pro-Gly-Pro (Zolotarev et al., 2006). Small modifications alter its chemistry. N-terminal acetylation (Ac-Semax) changed the structure and redox behavior of the copper(II) complex and removed the protection against copper toxicity in SH-SY5Y neuroblastoma cells that the authors tied to Semax's free N-terminus (Magrì et al., 2016). In APPswe/PS1dE9 transgenic mice, Semax and a derivative with two substitutions, Met-Glu-Asp-Arg-Pro-Gly-Pro, both raised maze and object recognition scores and reduced amyloid plaque counts (Radchenko et al., 2025). Neither Ac-Semax nor that derivative is Adamax.
What remains uncertain
No peer-reviewed study of Adamax appears in PubMed under that name or code. No cell, animal or human study of Adamax is on record.
The evidence label describes the linked research, not the suitability of a catalog product for use in people. Formulation, identity, purity, and measured content must be assessed separately.
Sources & studies
Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. ↗
Dolotov OV, et al. "Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain." J Neurochem. 2006. PMID 16635254. DOI 10.1111/j.1471-4159.2006.03658.x. Parent peptide Semax: rat membrane binding and BDNF.
Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. ↗
Dolotov OV, et al. "Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus." Brain Res. 2006. PMID 16996037. DOI 10.1016/j.brainres.2006.07.108. Parent peptide Semax: rat hippocampal BDNF and trkB.
The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. ↗
Medvedeva EV, et al. "The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis." BMC Genomics. 2014. PMID 24661604. DOI 10.1186/1471-2164-15-228. Parent peptide Semax: rat focal ischemia.
Influence of the N-terminus acetylation of Semax, a synthetic analog of ACTH(4-10), on copper(II) and zinc(II) coordination and biological properties. ↗
Magrì A, et al. "Influence of the N-terminus acetylation of Semax, a synthetic analog of ACTH(4-10), on copper(II) and zinc(II) coordination and biological properties." J Inorg Biochem. 2016. PMID 27586814. DOI 10.1016/j.jinorgbio.2016.08.013. Ac-Semax and Semax: metal chemistry and SH-SY5Y cells.
The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease. ↗
Radchenko AI, et al. "The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease." Acta Naturae. 2025. PMID 41479572. DOI 10.32607/actanaturae.27808. Semax and a two-substitution derivative in transgenic mice.
Zolotarev et al., 2006 ↗
Referenced in the existing DA guide; see the linked record for bibliographic details.
Read the full paper for its design, controls and limitations. A source link is not a claim that its tested material matches a DA formulation.
Catalog formats & documentation
Formats grouped by compound identity. Availability and batch documentation remain on Disguised Alpha.
Original DA reference: Adamax (DW 1032) research guide ↗
